We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Sanofi | EU:SAN | Euronext | Ordinary Share |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.60 | -0.65% | 91.30 | 91.12 | 91.90 | 92.24 | 91.09 | 91.83 | 891,417 | 16:40:00 |
By Kim Richters
Sanofi SA said Monday that it has agreed to sell some brands from its consumer healthcare portfolio in Europe to STADA Arzneimittel AG in an effort to streamline the section.
The French pharmaceutical company said the agreement covers registrations, trademarks and related commercial rights for 16 products in Europe.
Sanofi said it doesn't expect its European staff to be affected on account of the deal, which it assumes will close in the third quarter of this year.
In a separate release, Germany-based STADA said the deal includes products like the cough remedies Silomat and the skincare range Viscontour. It said most of the portfolio's annual turnover was currently generated in Germany, France, Spain, Italy and Poland.
The companies didn't disclose financial terms of the agreement.
Write to Kim Richters at kim.richters@wsj.com
(END) Dow Jones Newswires
June 28, 2021 02:35 ET (06:35 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions